Study Stopped
The lab was acquired by another company and has put this study's samples on hold.
A Validated Necrosis Assay to Determine the Need for Revision Surgery in Metal-on-metal Total Hip Arthroplasty
1 other identifier
observational
174
1 country
1
Brief Summary
The purpose of the study is to develop a biomarker assay to be used as a diagnostic tool for adverse local tissue reaction, or tissue necrosis, in a metal on metal total hip replacement. A convenience sample of a total of 100 hip patients will be enrolled: 50 metal-on-metal revision hips, 25 metal-on-poly revision hips, and 25 pre-operative total hips (no implant, control group) will be enrolled. Preoperative blood serum samples and intraoperative synovial fluid will be obtained from all hips and used for biomarker testing. Additionally, intraoperative assessment of tissue necrosis will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2014
CompletedStudy Start
First participant enrolled
August 4, 2014
CompletedFirst Posted
Study publicly available on registry
August 5, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 17, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
ExpectedApril 30, 2025
April 1, 2025
3.8 years
July 17, 2014
April 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The number of patients with serum and synovial fluid biomarkers
Blood Serum and Synovial fluid will be tested using a multi-analyte assay test
participants will be followed for the duration of their hospital stay, an expected average of 2 hours
Secondary Outcomes (1)
The number of patients with tissue necrosis
participants will be followed for the duration of their hospital stay, an expected average of 2 hours
Study Arms (3)
Control
pre-operative total hip patients with no existing total hip implant
Metal on polyethylene
patients who have a failed metal on polyethylene total hip implant and are presenting for revision surgery
Metal on Metal
patients who have a failed metal on metal total hip implant and are presenting for revision surgery
Eligibility Criteria
A convenience sample of a total of 100 hip patients will be enrolled at orthopedic clinics.
You may qualify if:
- Patients presenting for a metal on metal hip revision who have cobalt and chromium metal ion levels tested within 6 months of the date of the planned revision surgery.
- Patients presenting for a metal on poly hip revision
- Revision hip patients must be greater than one year postoperative
- The diagnosis at the time of the index, or primary, hip replacement was osteoarthritis.
- Patients who have hip osteoarthritis but have not had a total hip surgery (control)
You may not qualify if:
- Patients presenting for a metal on metal hip revision who have cobalt and chromium metal ion levels tested \>6 months of the date of the planned revision
- Patients with a total hip on the contralateral side.
- Patients with a prior history of periprosthetic infection
- Revision cases where the diagnosis at the time of the index, or primary, hip replacement was not osteoarthritis.
- Prisoners
- Patients not willing to consent for the proposed treatment
- Patients with an altered mental status
- Active, concurrent metastatic infection
- Active, superficial infection
- Patients presenting for a metal on poly hip revision to treat trunionosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
OrthoCarolina
Charlotte, North Carolina, 28207, United States
Related Publications (9)
MacDonald SJ. Metal-on-metal total hip arthroplasty: the concerns. Clin Orthop Relat Res. 2004 Dec;(429):86-93. doi: 10.1097/01.blo.0000150309.48474.8b.
PMID: 15577471BACKGROUNDLindgren JU, Brismar BH, Wikstrom AC. Adverse reaction to metal release from a modular metal-on-polyethylene hip prosthesis. J Bone Joint Surg Br. 2011 Oct;93(10):1427-30. doi: 10.1302/0301-620X.93B10.27645.
PMID: 21969447BACKGROUNDLombardi AV Jr, Barrack RL, Berend KR, Cuckler JM, Jacobs JJ, Mont MA, Schmalzried TP. The Hip Society: algorithmic approach to diagnosis and management of metal-on-metal arthroplasty. J Bone Joint Surg Br. 2012 Nov;94(11 Suppl A):14-8. doi: 10.1302/0301-620X.94B11.30680.
PMID: 23118373BACKGROUNDCobb AG, Schmalzreid TP. The clinical significance of metal ion release from cobalt-chromium metal-on-metal hip joint arthroplasty. Proc Inst Mech Eng H. 2006 Feb;220(2):385-98. doi: 10.1243/09544119JEIM78.
PMID: 16669404BACKGROUNDMabilleau G, Kwon YM, Pandit H, Murray DW, Sabokbar A. Metal-on-metal hip resurfacing arthroplasty: a review of periprosthetic biological reactions. Acta Orthop. 2008 Dec;79(6):734-47. doi: 10.1080/17453670810016795.
PMID: 19085489BACKGROUNDTower SS. Arthroprosthetic cobaltism: neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty: a case report. J Bone Joint Surg Am. 2010 Dec 1;92(17):2847-51. doi: 10.2106/JBJS.J.00125. Epub 2010 Oct 29. No abstract available.
PMID: 21037026BACKGROUNDCampbell P, Ebramzadeh E, Nelson S, Takamura K, De Smet K, Amstutz HC. Histological features of pseudotumor-like tissues from metal-on-metal hips. Clin Orthop Relat Res. 2010 Sep;468(9):2321-7. doi: 10.1007/s11999-010-1372-y.
PMID: 20458645BACKGROUNDLeopold SS, Berger RA, Patterson L, Skipor AK, Urban RM, Jacobs JJ. Serum titanium level for diagnosis of a failed, metal-backed patellar component. J Arthroplasty. 2000 Oct;15(7):938-43. doi: 10.1054/arth.2000.6632.
PMID: 11061457BACKGROUNDGriffin WL, Fehring TK, Kudrna JC, Schmidt RH, Christie MJ, Odum SM, Dennos AC. Are metal ion levels a useful trigger for surgical intervention? J Arthroplasty. 2012 Sep;27(8 Suppl):32-6. doi: 10.1016/j.arth.2012.03.020. Epub 2012 May 17.
PMID: 22608683BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Fehring, MD
OrthoCarolina Research Institute, Inc.
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2014
First Posted
August 5, 2014
Study Start
August 4, 2014
Primary Completion
May 17, 2018
Study Completion (Estimated)
December 31, 2030
Last Updated
April 30, 2025
Record last verified: 2025-04